Mo Sajanlal is a Senior Managing Director on the Institutional Equities and Derivatives teams at Leerink Partners.
Prior to joining the Firm in 2018, Mo covered the Biotechnology and Specialty Pharmaceuticals sectors as an equity research analyst at Bank of America and at Barclays. He also worked in Corporate Finance and Business Development at Pfizer and in Sales at Eli Lilly.
He earned an M.B.A. from NYU Stern and a B.A. in Neuroscience from the University of Virginia.